| Comparison of ddI Versus Zidovudine in HIV-Infected Patients (NCT00000979) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Tecogalan Sodium (NCT00002342) | Daiichi Pharmaceuticals | |
| A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells (NCT00000822) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment (NCT00012519) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules (NCT00001043) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients (NCT00001030) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV) (NCT00002026) | Glaxo Wellcome | |
| A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3 (NCT00002161) | Gilead Sciences | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis (NCT00002305) | Pfizer | |
| Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients (NCT00000821) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea (NCT00002252) | Sandoz | |
| The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients (NCT00000861) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study) (NCT00027352) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients (NCT00002450) | Gilead Sciences | |
| Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent (NCT00002029) | Abbott | |
| An HIV Vaccine Preparedness Study (NCT00000915) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies (NCT00002210) | Pharmacia and Upjohn | |
| A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine (NCT00000720) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease (NCT00000696) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Megace in HIV-Infected Women (NCT00002345) | Bristol-Myers Squibb | |
| Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment (NCT00011128) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis (NCT00004736) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant Women (NCT01443117) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past (NCT00002320) | Glaxo Wellcome | |
| A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs (NCT00002162) | Hoffmann-La Roche | |
| A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia (NCT00002042) | Ortho Pharmaceuticals | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002432) | Astra USA | |
| Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052 (NCT00091416) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules (NCT00001076) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs (NCT00002328) | Pfizer | |
| Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults (NCT00073216) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals (NCT00002189) | Baker Norton Pharmaceuticals | |
| Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care (NCT00028327) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults (NCT00111605) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease (NCT00002337) | Otsuka America Pharmaceutical | |
| An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy (NCT00002089) | Pfizer | |
| Effects of Changing HIV Therapy at Lower Versus Higher Viral Loads (NCT00036465) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members (NCT00000703) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients (NCT00002373) | Glaxo Wellcome | |
| Use of a Test That Evaluates How the Body Handles Insulin and Glucose (NCT00027092) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers (NCT00000871) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS (NCT00001999) | American National Red Cross | |
| HIV Prevention Counseling for Men Who Have Sex With Men (NCT00000931) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain (NCT00089557) | NeurogesX | |
| A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis (NCT00005921) | Merck Sharp & Dohme LLC | |
| Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea (NCT00002121) | VA Medical Center-Gainesville | |
| A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) (NCT00000804) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis (NCT00000639) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml (NCT00002172) | The Immune Response Corporation | |
| Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs (NCT00050921) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients (NCT00002326) | Gilead Sciences | |
| Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS (NCT00164385) | Centers for Disease Control and Prevention | |
| Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine (NCT00000635) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine (NCT00002280) | Bristol-Myers Squibb | |
| A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC (NCT00000753) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis (NCT00000708) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens (NCT00001091) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS (NCT00002273) | Hoffmann-La Roche | |
| A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy (NCT00000969) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells (NCT00000667) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers (NCT00098163) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. (NCT00002133) | Janssen, LP | |
| The Safety and Effectiveness of Two Forms of Saquinavir Combined With Other Anti-HIV Drugs in HIV-Infected Infants and Children (NCT00002380) | Hoffmann-La Roche | |
| A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) (NCT00000922) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals (NCT00000736) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol (NCT00000799) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole (NCT00001996) | Glaxo Wellcome | |
| Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) (NCT00005002) | Agouron Pharmaceuticals | |
| Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults (NCT00100581) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir (NCT00000898) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common (NCT00002325) | Pfizer | |
| An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies (NCT00002118) | Hoffmann-La Roche | |
| A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons (NCT00002130) | Otsuka America Pharmaceutical | |
| A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults. (NCT00001044) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals (NCT00000633) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections (NCT00000858) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers (NCT00002261) | Bristol-Myers Squibb | |
| An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen (NCT00002205) | Glaxo Wellcome | |
| Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis (NCT00000794) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3 (NCT00000756) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines (NCT00056745) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo (NCT00002101) | Pharmacia | |
| Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo) (NCT00000765) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. (NCT00000764) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients (NCT00002363) | Columbia Research Laboratories | |
| Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients (NCT00000906) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir (NCT00001133) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma (NCT00000660) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Immune System Activity in Healthy Adults (NCT00014053) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease (NCT00000881) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. (NCT00002192) | Anderson Clinical Research | |
| A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation (NCT00036452) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia (NCT00000705) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS (NCT00000975) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients (NCT00001084) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients (NCT00002178) | Hoffmann-La Roche | |
| A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy (NCT00000842) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00002105) | Sequus Pharmaceuticals | |
| A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP (NCT00000700) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa (NCT01927835) | National Institute of Allergy and Infectious Diseases (NIAID) | |